📰 Amgen News
Page 44 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
May 16, 2024
As we previously reported, the Judicial Panel on Multidistrict Litigation recently granted Regeneron Pharmaceutical's ("Regeneron") motion to establish a multi-district litigation ("MDL")...
May 16, 2024
Foundations Investment Advisors LLC lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 6.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,758 shares of the medical research company’s stock after selling 979 shares during the […]
May 16, 2024
As we previously reported, the Judicial Panel on Multidistrict Litigation recently granted Regeneron Pharmaceuticals motion to establish a multi-district litigation for its aflibercept BPCIA...
May 16, 2024
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.
May 16, 2024
DHD Films Announces Appointment of Jim Hicks as Head of Strategy and Innovation
May 16, 2024
Fitch Ratings has affirmed and subsequently withdrawn Pfizer, Inc.s, Wyeth LLCs and Pharmacia Corp.s ratings, including their A Issuer Default Ratings and senior unsecured debt ratings at...
May 16, 2024
Imagine your billion dollar win wiped out later. You'd be mad. You'd wonder how that happened. You'd ask if you did anything wrong to deserve that wipe out.
May 16, 2024
The U.S. Food and Drug Administration granted accelerated approval to tarlatamab, Amgens targeted immunotherapy for treating adults with advanced small cell lung cancer that has worsened despite...